Prostatic Neoplasms, Castration-Resistant Recruiting Phase Trials for Radium Ra 223 Dichloride (DB08913)

IndicationStatusPhase
DBCOND0001230 (Prostatic Neoplasms, Castration-Resistant)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02450812Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany